Craft

Mauna Kea Technologies

Stock Price

€0.5

2023-10-09

Market Capitalization

€30.1 M

2023-10-09

Revenue

€8.2 M

FY, 2025

Mauna Kea Technologies Summary

Company Summary

Overview
Mauna Kea Technologies is a company that manufactures and sells medical devices. It specializes in the areas of gastroenterology, pulmonology, and urology. The company also developed a Cellvizio real-time in vivo cellular imaging platform that enables physicians to monitor the progression of diseases.
Type
Public
Status
Active
Founded
2000
HQ
Paris, FR | view all locations
Website
https://www.maunakeatech.com
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • François Lacombe

    François Lacombe, Chief Scientific Officer

    • Christopher D. McFadden

      Christopher D. McFadden, Board Member

      • Aline Criton

        Aline Criton, Chief Clinical and Regulatory Affairs Officer

      • Claire Biot

        Claire Biot, Board Member

        LocationsView all

        1 location detected

        • Paris, IDF HQ

          France

          9 Rue d'Enghien

        Mauna Kea Technologies Financials

        Summary Financials

        Revenue (FY, 2025)
        €8.2M
        Gross profit (FY, 2025)
        €7.9M
        Net income (FY, 2025)
        €10.8M
        Cash (FY, 2025)
        €5.0M
        EBIT (FY, 2025)
        (€9.1M)
        Enterprise value
        $37.2M

        Footer menu